Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 7 studies | 37% ± 18% | |
endothelial cell | 6 studies | 27% ± 14% | |
endothelial cell of lymphatic vessel | 5 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 5 studies | 21% ± 6% | |
type I pneumocyte | 4 studies | 22% ± 7% | |
cardiac muscle cell | 3 studies | 16% ± 0% | |
GABAergic neuron | 3 studies | 41% ± 6% | |
glutamatergic neuron | 3 studies | 42% ± 4% | |
ependymal cell | 3 studies | 28% ± 14% | |
fibroblast | 3 studies | 29% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 957.29 | 653 / 653 | 93% | 3.67 | 562 / 605 |
brain | 86% | 247.71 | 2262 / 2642 | 97% | 3.90 | 682 / 705 |
pancreas | 100% | 656.16 | 328 / 328 | 74% | 1.58 | 131 / 178 |
prostate | 100% | 884.64 | 245 / 245 | 73% | 1.58 | 368 / 502 |
adrenal gland | 100% | 680.74 | 258 / 258 | 72% | 1.79 | 165 / 230 |
intestine | 99% | 647.96 | 961 / 966 | 69% | 1.56 | 365 / 527 |
lung | 100% | 773.02 | 578 / 578 | 65% | 1.48 | 754 / 1155 |
breast | 100% | 768.42 | 459 / 459 | 60% | 1.25 | 672 / 1118 |
kidney | 96% | 359.56 | 85 / 89 | 62% | 1.24 | 559 / 901 |
stomach | 97% | 448.01 | 347 / 359 | 57% | 1.37 | 164 / 286 |
esophagus | 99% | 613.09 | 1435 / 1445 | 54% | 1.34 | 99 / 183 |
skin | 95% | 460.81 | 1726 / 1809 | 57% | 1.36 | 269 / 472 |
uterus | 100% | 1335.98 | 170 / 170 | 52% | 1.48 | 239 / 459 |
bladder | 100% | 736.10 | 21 / 21 | 44% | 1.05 | 224 / 504 |
ovary | 100% | 1886.71 | 180 / 180 | 35% | 0.62 | 151 / 430 |
blood vessel | 100% | 808.19 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 669.07 | 1203 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 370.95 | 238 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 422.83 | 837 / 861 | 0% | 0 | 0 / 0 |
muscle | 68% | 143.68 | 546 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 40% | 191.28 | 369 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 0.80 | 16 / 45 |
eye | 0% | 0 | 0 / 0 | 28% | 0.57 | 22 / 80 |
liver | 2% | 2.86 | 4 / 226 | 9% | 0.18 | 35 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0032259 | Biological process | methylation |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1903053 | Biological process | regulation of extracellular matrix organization |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0008168 | Molecular function | methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRDM5 |
Protein name | PR/SET domain 5 PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5) Alternative protein PRDM5 |
Synonyms | PFM2 |
Description | FUNCTION: Sequence-specific DNA-binding transcription factor. Represses transcription at least in part by recruitment of the histone methyltransferase EHMT2/G9A and histone deacetylases such as HDAC1. Regulates hematopoiesis-associated protein-coding and microRNA (miRNA) genes. May regulate the expression of proteins involved in extracellular matrix development and maintenance, including fibrillar collagens, such as COL4A1 and COL11A1, connective tissue components, such as HAPLN1, and molecules regulating cell migration and adhesion, including EDIL3 and TGFB2. May cause G2/M arrest and apoptosis in cancer cells. . |
Accessions | H0Y9S1 ENST00000394435.2 [Q9NQX1-3] ENST00000515109.5 [Q9NQX1-4] ENST00000502409.1 L0R6M5 ENST00000428209.6 [Q9NQX1-2] Q9NQX1 ENST00000264808.8 [Q9NQX1-1] |